ClinicalTrials.govpublic full text
Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
atrial fibrillation (af), chronic lymphocytic leukemia, waldenstrom macroglobulinemia, mantle cell lymphoma, marginal zone lymphoma, bruton's tyrosine kinase inhibitor, btki, ibrutinib, acalabrutinib, zanubrutinib, cardio-oncology, ecg patch monitor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 881808
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.